These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8728116

  • 1. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D.
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [Abstract] [Full Text] [Related]

  • 2. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D.
    Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D, Vandenabeele P, Declercq W, Van de Craen M, Grooten J, Fiers W.
    Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
    [Abstract] [Full Text] [Related]

  • 4. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W.
    Nature; 1993 Jan 21; 361(6409):266-9. PubMed ID: 8380906
    [Abstract] [Full Text] [Related]

  • 5. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R, Milleck J, Korobko VG, Shingarova LN, Schmidt HE.
    Eur Cytokine Netw; 1992 Jan 21; 3(4):381-90. PubMed ID: 1330049
    [Abstract] [Full Text] [Related]

  • 6. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
    Alaaeddine N, DiBattista JA, Pelletier JP, Cloutier JM, Kiansa K, Dupuis M, Martel-Pelletier J.
    J Rheumatol; 1997 Oct 21; 24(10):1985-94. PubMed ID: 9330943
    [Abstract] [Full Text] [Related]

  • 7. Biological activity of mutants of human tumour necrosis factor-alpha.
    Kircheis R, Milleck J, Korobko VG, Shingarova LN, Behnke D, Schmidt HE.
    Immunology; 1992 Jul 21; 76(3):433-8. PubMed ID: 1526652
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W, Vandenabeele P, Fiers W.
    Cytokine; 1995 Oct 21; 7(7):701-9. PubMed ID: 8580379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.
    Clin Cancer Res; 1996 Sep 21; 2(9):1523-31. PubMed ID: 9816329
    [Abstract] [Full Text] [Related]

  • 14. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S, Mattka B, Al-Ward R, Lorenz HM, Manger B, Pfizenmaier K, Grell M, Kalden JR.
    J Rheumatol; 1999 Mar 21; 26(3):645-53. PubMed ID: 10090177
    [Abstract] [Full Text] [Related]

  • 15. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.
    Van Ostade X, Vandenabeele P, Tavernier J, Fiers W.
    Eur J Biochem; 1994 Mar 15; 220(3):771-9. PubMed ID: 8143731
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells.
    Ikegami H, Arai N, Moriyasu J, Taniguchi M, Tsusaki K, Honji N, Kohno K, Ando S, Kurimoto M.
    Lymphokine Cytokine Res; 1993 Jun 15; 12(3):173-80. PubMed ID: 7688581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [TNF].
    Yamauchi N, Niitsu Y.
    Gan To Kagaku Ryoho; 1997 Sep 15; 24(11):1486-94. PubMed ID: 9309146
    [Abstract] [Full Text] [Related]

  • 19. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT, Yan XR, Huang GJ, Xu CX, Chai YS, Zhang ZQ.
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov 15; 19(6):730-3. PubMed ID: 15971588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.